Journal Information
Vol. 30. Issue 10.
Pages 498-505 (December 1994)
Share
Share
Download PDF
More article options
Vol. 30. Issue 10.
Pages 498-505 (December 1994)
Full text access
Estrategia terapéutica en la enfermedad tromboembólica venosa (ETV)
Visits
4091
J. Blanquer Olivas, M.A. Cabezudo Hernández, A. Capelastegui Sáiz, V. Gil Suay, M.A. De Gregorio Ariza, J.L. Lobo Beristain, D. Nauffal Mansur, M. Oribe Ibáñez, J. Ruiz Manzano, F. Ruiz Montait, R. Vidal Pía, Grupo de Trabajo TEP de la SEPAR
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
R. Collins, A. Scrimgeour, S. Yusuf, R. Peto.
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin OverView of results of randomised trials in general, orthopedic and urologic surgery.
N Engl J Med, 318 (1988), pp. 1.162-1.173
[2.]
T.M. Hyers, R.D. Hull, J.G. Weg.
Antithrombotic therapy for venous Thromboembolic disease.
Chest, 102 (1992), pp. 408S-425S
[3.]
H.H. Gray, S. Firoozan.
Management of pulmonary embolism.
Thorax, 47 (1992), pp. 825-832
[4.]
K.M. Moser.
Venous thromboembolism.
Am Rev Respir Dis, 141 (1990), pp. 235-249
[5.]
C. Thèry, J.J. Bauchart, M. Lesenne, P. Asseman, J.G. Flajollet, R. Legghe, et al.
Predictive factors of effectiveness of streptokinase in deep venous thrombosis.
Am J Cardiol, 69 (1992), pp. 117-122
[6.]
J. Hirsh.
Heparin..
N Engl J Med, 324 (1991), pp. 1.565-1.574
[7.]
M.N. Levine, J. Hirsh, S. Landefeld, G. Raskob.
Hemorragic complications of anticoagulant treatment.
Chest, 102 (1992), pp. 352S-363S
[8.]
R.D. Hull, G.E. Raskob, D. Rosembloom, J. Lemaire, G.F. Pineo, B. Baylis, et al.
Optimal therapeutic level of heparin therapy in patients with venous thrombosis.
Arch Intern Med, 152 (1992), pp. 1.589-1.595
[9.]
R.D. Hull, G.E. Raskob, D. Rosenbloom, A.A. Panju, P. Brill-Edwards, J.S. Ginsberg, et al.
Heparin for five days as compared with ten days in the initial treatment of proximal venous thrombosis.
N Engl J Med, 322 (1990), pp. 1.260-1.264
[10.]
J. Hirsh, J.E. Dalen, D. Deykin, L. Poller.
Hepar Mechanism of action pharmacokinetics dosing considerations monitoring efficacy safety..
Chest, 102 (1992), pp. 337S-351S
[11.]
J.J. Heillman.
Traitment des thromboses veneuses profondes constituées..
Rev Med Interne, 10 (1989), pp. 375-381
[12.]
G. Simmoneau, B. Charbonier, H. Decousus, B. Planchon, J. Ninet, P. Sie, et al.
Subcutaneous low-molecular-weight heparin in the treatment of proximal deep vein thrombosis.
Arch Intern Med, 153 (1993), pp. 1.541-1.546
[13.]
P. Prandoni, A.W. Lensing, H.R. Buller, M. Carta, A. Cogo, M. Vigo, et al.
Comparison of subcutaneous low-molecular weight heparin with intravenous standard heparin in proximal deep-vein thrombosis.
Lancet, 339 (1992), pp. 441-445
[14.]
R.D. Hull, G.E. Raskob, G.F. Pineo, D. Green, A.A. Trowbridge, G.G. Elliott, et al.
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.
N Engl J Med, 326 (1992), pp. 975-982
[15.]
J. Hirsh.
Oral anticoagulants drugs.
N Engl J Med, 324 (1991), pp. 1.865-1.875
[16.]
S.Z. Goldhaber, M. Morpurgo.
Diagnosis, treatment, and prevention of pulmonary embolism Report of the WHO/International Society and Federation of Cardiology Task Force.
JAMA, 268 (1992), pp. 1.727-1.733
[17.]
M.D. Friedman.
Oral Anticoagulants: Pharmacodinamics, clinical indications and adverse effects.
J Clin Pharmacol, 32 (1992), pp. 196-209
[18.]
L.Q. Rogers, C.L. Lutcher.
Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature.
Am J Med, 88 (1990), pp. 389-395
[19.]
Tissue Plasminogen Activator for the Treatment of Acute Pulmonary Embolism:, A., Collaborative Study by the, PIOPED., Investigators.
Chest, 97 (1990), pp. 528-533
[20.]
Urokinase Pulmonary Embolism, Trial, A., cooperative study.
Phase 1 Results.
JAMA, 214 (1974), pp. 2.163-2.172
[21.]
Urokinase-Streptokinase Embolism Trial.
A cooperative study Phase 2 results..
JAMA, 229 (1974), pp. 1.606-1.613
[22.]
F. Schwarz, H. Stehr, R. Zimmerman, J. Manthey, W. Kubler.
Sustained improvement of pulmonary hemodinamics in patients a rest and during exercise after thrombolytic treatment of massive pulmonary embolism.
Circulation, 71 (1985), pp. 117-123
[23.]
G.V.R.K. Sharma, V.A. Burleron, A.A. Sasahara.
Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism.
N Engl J Med, 303 (1980), pp. 842-845
[24.]
B.A. Cooper, J.R. Leclerc.
OverView of Hemostasis and Blood Coagulation. Venous Thromboembolic Disorders., pp. 1-16
[25.]
J. Loscalzo, E. Braunwald.
Tissue Plasminogen Activator.
N Engl J Med, 319 (1988), pp. 925-931
[26.]
National Institutes of Health Consensus Panel Thrombolytic Therapy in Thrombosis:, A., National Institutes of Health Consensus Development Conference.
Ann Intern Med, 93 (1980), pp. 141-144
[27.]
A.A. Sasahara, C.A. St. Martin, J. Jenkin, W.M. Barker.
Approach the Patient with Venous Thromboembolism.
Treatment with Thrombolytic Agents. Hematology/Oncology Clinics of North America, 6 (1992), pp. 1.141-1.159
[28.]
D.R. Hirsch, S.Z. Goldhaber.
Bleeding Time and other Laboratory tests to Monitor the Safety and Efficacy of Thrombolytic Therapy.
Chest, 97 (1990), pp. 124S-131S
[29.]
A. Markel, R.A. Manzo, D.E. Strandness Jr..
The Potential Role of Thrombolytic Therapy in Venous Thrombosis.
Arch Intern Med, 152 (1992), pp. 1.265-1.267
[30.]
J.V. Marder, B. Brenner, S. Totterman, C.H.W. Francis, R. Rubin, A.K. Rao, et al.
Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis.
J Lab Clin Med, 119 (1992), pp. 485-495
[31.]
P.F. Lawrence, G.R. Goodman.
Thrombolytic Therapy. Surgical Clinics of North America, 72 (1992), pp. 899-918
[32]
M. Rubenstein, W.P. Cruger.
Successful Streptokinase therapy for catheter-induced subclavian vein thrombosis.
Arch Intern Med, 140 (1980), pp. 1.370-1.371
[33]
E. Tovar, M. Marini, P. Díaz, S. Martínez, J.M. Castro, A. Gayoso, et al.
Fibrinólisis locorregional con Urokinasa en el tratamiento de la trombosis venosa profunda.
Angiología, 6 (1989), pp. 233-237
[34]
A.G.G. Turpie.
Thrombolytic therapy in venous thrombosis..
Thrombolysis Yearbook 1993 Amsterdam: Excerpta Medica, pp. 131-141
[35]
A.G.G. Turpie, M.N. Levine, J. Hirsh, J.S. Ginsberg, M. Cruickshank, R. Jay, et al.
Tissue plasminogen activator (rt-PA) vs heparin in thrombosis.
Results of a randomized trial. Chest, 97 (1990), pp. 172S-175S
[36]
M. Martin, B.J.O. Fiebach.
Short-therm ultrahigh streptokinase treatment of chronic arterial occlusions and acute deep vein thrombosis.
Semin Thromb Hemost, 17/1 (1991), pp. 21-38
[37]
S.Z. Goldhaber, M.F. Meyerovitz, D. Green, R.L. Vogelzang, P. Citrin, J. Heit, et al.
Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis.
Am J Med, 88 (1990), pp. 235-240
[38]
R. Zimmerman, A. Gürsoy, A. Horm, J. Harenberg, C. Diehm, W. Kuble.
Fibrinolytic therapy of deep vein thrombosis with continuous intravenous of a recombinant tissue plasminogen activator.
Semin Thromb Hemostasis, 17/1 (1991), pp. 48-54
[39]
V.J. Marder, S. Sherry.
Thrombolytic Therapy: Current Status (Second of two parts).
N Engl J Med, 318 (1988), pp. 1.585-1.595
[40]
S. Sherry.
Thrombolytic Therapy for Acute Pulmonary Embolism.
Fibrinolysis, Thrombosis and Hemostasis., pp. 229-230
[41]
R.D. Anderson, M.N. Levine.
Thrombolytic therapy for the treatment of acute pulmonary embolism.
Can Med Assoc J, 146 (1992), pp. 1.317-1.324
[42]
J.A. Parker, J.E. Markis, A. Palla, et al.
Early improvement in pulmonary perfusion after rt-PA therapy for acute embolism: segmental perfusion sean analysis.
Radiology, 166 (1988), pp. 441-445
[43]
G. Agnelli.
Rationale for bolus t-PA therapy to improve efficacy and safety.
Chest, 97 (1990), pp. 161S-167S
[44]
M.N. Levine, J. Hirsh, J. Weitz, M. Cruickshank, J. Neemen, A.G. Turpie, et al.
A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
Chest, 98 (1990), pp. 1.473-1.479
[45]
G. Pacouret, B. Charbonnier, B. Delahousse, P. Fournier.
Pilot study of a 50 mg over 10 minutes alteplase regimen in massive pulmonary embolism [resumen]., J Am Coll Cardiol.
, 19 (1992), pp. 315A
[46]
PIOPED., investigators.
Value of the ventilation/perfusion scan in acute pulmonary embolism Results of the Investigation of Pulmonary Embolism Diagnosis (PIOPED).
J Am Med Assoc, 263 (1990), pp. 2.753-2.759
Copyright © 1994. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?